Pemphigus Vulgaris Market Size, Share & Trends Report

Pemphigus Vulgaris Market (2025 - 2033) Size, Share & Trends Analysis Report By Therapy Type (Anti-CD20 Monoclonal Antibodies, Systemic Corticosteroids, Topical therapies), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By Region, And Segment Forecasts

Market Segmentation

Pemphigus Vulgaris Therapy Type Outlook (Revenue, USD Million, 2021 - 2033)
- Anti-CD20 monoclonal antibodies (rituximab)
- Systemic corticosteroids
- Conventional steroid-sparing immunosuppressants
- Intravenous immunoglobulin (IVIG) - adjunct
- Topical therapies
Pemphigus Vulgaris Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Others
Pemphigus Vulgaris Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
  - North America Pemphigus Vulgaris Market, by Therapy Type
    - Anti-CD20 monoclonal antibodies (rituximab)
    - Systemic corticosteroids
    - Conventional steroid-sparing immunosuppressants
    - Intravenous immunoglobulin (IVIG) - adjunct
    - Topical therapies
  - North America Pemphigus Vulgaris Market, by Distribution Channel
    - Hospital Pharmacies
    - Retail Pharmacies
    - Others
  - U.S.
    - U.S. Pemphigus Vulgaris Market, by Therapy Type
      - Anti-CD20 monoclonal antibodies (rituximab)
      - Systemic corticosteroids
      - Conventional steroid-sparing immunosuppressants
      - Intravenous immunoglobulin (IVIG) - adjunct
      - Topical therapies
    - U.S. Pemphigus Vulgaris Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Canada
    - Canada Pemphigus Vulgaris Market, by Therapy Type
      - Anti-CD20 monoclonal antibodies (rituximab)
      - Systemic corticosteroids
      - Conventional steroid-sparing immunosuppressants
      - Intravenous immunoglobulin (IVIG) - adjunct
      - Topical therapies
    - Canada Pemphigus Vulgaris Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Mexico
    - Mexico Pemphigus Vulgaris Market, by Therapy Type
      - Anti-CD20 monoclonal antibodies (rituximab)
      - Systemic corticosteroids
      - Conventional steroid-sparing immunosuppressants
      - Intravenous immunoglobulin (IVIG) - adjunct
      - Topical therapies
    - Mexico Pemphigus Vulgaris Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
- Europe
  - Europe Pemphigus Vulgaris Market, by Therapy Type
    - Anti-CD20 monoclonal antibodies (rituximab)
    - Systemic corticosteroids
    - Conventional steroid-sparing immunosuppressants
    - Intravenous immunoglobulin (IVIG) - adjunct
    - Topical therapies
  - Europe Pemphigus Vulgaris Market, by Distribution Channel
    - Hospital Pharmacies
    - Retail Pharmacies
    - Others
  - UK
    - UK Pemphigus Vulgaris Market, by Therapy Type
      - Anti-CD20 monoclonal antibodies (rituximab)
      - Systemic corticosteroids
      - Conventional steroid-sparing immunosuppressants
      - Intravenous immunoglobulin (IVIG) - adjunct
      - Topical therapies
    - UK Pemphigus Vulgaris Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Germany
    - Germany Pemphigus Vulgaris Market, by Therapy Type
      - Anti-CD20 monoclonal antibodies (rituximab)
      - Systemic corticosteroids
      - Conventional steroid-sparing immunosuppressants
      - Intravenous immunoglobulin (IVIG) - adjunct
      - Topical therapies
    - Germany Pemphigus Vulgaris Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - France
    - France Pemphigus Vulgaris Market, by Therapy Type
      - Anti-CD20 monoclonal antibodies (rituximab)
      - Systemic corticosteroids
      - Conventional steroid-sparing immunosuppressants
      - Intravenous immunoglobulin (IVIG) - adjunct
      - Topical therapies
    - France Pemphigus Vulgaris Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Italy
    - Italy Pemphigus Vulgaris Market, by Therapy Type
      - Anti-CD20 monoclonal antibodies (rituximab)
      - Systemic corticosteroids
      - Conventional steroid-sparing immunosuppressants
      - Intravenous immunoglobulin (IVIG) - adjunct
      - Topical therapies
    - Italy Pemphigus Vulgaris Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Spain
    - Spain Pemphigus Vulgaris Market, by Therapy Type
      - Anti-CD20 monoclonal antibodies (rituximab)
      - Systemic corticosteroids
      - Conventional steroid-sparing immunosuppressants
      - Intravenous immunoglobulin (IVIG) - adjunct
      - Topical therapies
    - Spain Pemphigus Vulgaris Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Denmark
    - Denmark Pemphigus Vulgaris Market, by Therapy Type
      - Anti-CD20 monoclonal antibodies (rituximab)
      - Systemic corticosteroids
      - Conventional steroid-sparing immunosuppressants
      - Intravenous immunoglobulin (IVIG) - adjunct
      - Topical therapies
    - Denmark Pemphigus Vulgaris Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Sweden
    - Sweden Pemphigus Vulgaris Market, by Therapy Type
      - Anti-CD20 monoclonal antibodies (rituximab)
      - Systemic corticosteroids
      - Conventional steroid-sparing immunosuppressants
      - Intravenous immunoglobulin (IVIG) - adjunct
      - Topical therapies
    - Sweden Pemphigus Vulgaris Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Norway
    - Norway Pemphigus Vulgaris Market, by Therapy Type
      - Anti-CD20 monoclonal antibodies (rituximab)
      - Systemic corticosteroids
      - Conventional steroid-sparing immunosuppressants
      - Intravenous immunoglobulin (IVIG) - adjunct
      - Topical therapies
    - Norway Pemphigus Vulgaris Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
- Asia Pacific
  - Asia Pacific Pemphigus Vulgaris Market, by Therapy Type
    - Anti-CD20 monoclonal antibodies (rituximab)
    - Systemic corticosteroids
    - Conventional steroid-sparing immunosuppressants
    - Intravenous immunoglobulin (IVIG) - adjunct
    - Topical therapies
  - Asia Pacific Pemphigus Vulgaris Market, by Distribution Channel
    - Hospital Pharmacies
    - Retail Pharmacies
    - Others
  - Japan
    - Japan Pemphigus Vulgaris Market, by Therapy Type
      - Anti-CD20 monoclonal antibodies (rituximab)
      - Systemic corticosteroids
      - Conventional steroid-sparing immunosuppressants
      - Intravenous immunoglobulin (IVIG) - adjunct
      - Topical therapies
    - Japan Pemphigus Vulgaris Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - China
    - Japan Pemphigus Vulgaris Market, by Therapy Type
      - Anti-CD20 monoclonal antibodies (rituximab)
      - Systemic corticosteroids
      - Conventional steroid-sparing immunosuppressants
      - Intravenous immunoglobulin (IVIG) - adjunct
      - Topical therapies
    - Japan Pemphigus Vulgaris Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - India
    - India Pemphigus Vulgaris Market, by Therapy Type
      - Anti-CD20 monoclonal antibodies (rituximab)
      - Systemic corticosteroids
      - Conventional steroid-sparing immunosuppressants
      - Intravenous immunoglobulin (IVIG) - adjunct
      - Topical therapies
    - India Pemphigus Vulgaris Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Australia
    - Australia Pemphigus Vulgaris Market, by Therapy Type
      - Anti-CD20 monoclonal antibodies (rituximab)
      - Systemic corticosteroids
      - Conventional steroid-sparing immunosuppressants
      - Intravenous immunoglobulin (IVIG) - adjunct
      - Topical therapies
    - Australia Pemphigus Vulgaris Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - South Korea
    - South Korea Pemphigus Vulgaris Market, by Therapy Type
      - Anti-CD20 monoclonal antibodies (rituximab)
      - Systemic corticosteroids
      - Conventional steroid-sparing immunosuppressants
      - Intravenous immunoglobulin (IVIG) - adjunct
      - Topical therapies
    - South Korea Pemphigus Vulgaris Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Thailand
    - Thailand Pemphigus Vulgaris Market, by Therapy Type
      - Anti-CD20 monoclonal antibodies (rituximab)
      - Systemic corticosteroids
      - Conventional steroid-sparing immunosuppressants
      - Intravenous immunoglobulin (IVIG) - adjunct
      - Topical therapies
    - Thailand Pemphigus Vulgaris Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
- Latin America
  - Latin America Pemphigus Vulgaris Market, by Therapy Type
    - Anti-CD20 monoclonal antibodies (rituximab)
    - Systemic corticosteroids
    - Conventional steroid-sparing immunosuppressants
    - Intravenous immunoglobulin (IVIG) - adjunct
    - Topical therapies
  - Latin America Pemphigus Vulgaris Market, by Distribution Channel
    - Hospital Pharmacies
    - Retail Pharmacies
    - Others
  - Brazil
    - Brazil Pemphigus Vulgaris Market, by Therapy Type
      - Anti-CD20 monoclonal antibodies (rituximab)
      - Systemic corticosteroids
      - Conventional steroid-sparing immunosuppressants
      - Intravenous immunoglobulin (IVIG) - adjunct
      - Topical therapies
    - Brazil Pemphigus Vulgaris Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Argentina
    - Argentina Pemphigus Vulgaris Market, by Therapy Type
      - Anti-CD20 monoclonal antibodies (rituximab)
      - Systemic corticosteroids
      - Conventional steroid-sparing immunosuppressants
      - Intravenous immunoglobulin (IVIG) - adjunct
      - Topical therapies
    - Argentina Pemphigus Vulgaris Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
- Middle East & Africa
  - Middle East & Africa Pemphigus Vulgaris Market, by Therapy Type
    - Anti-CD20 monoclonal antibodies (rituximab)
    - Systemic corticosteroids
    - Conventional steroid-sparing immunosuppressants
    - Intravenous immunoglobulin (IVIG) - adjunct
    - Topical therapies
  - Middle East & Africa Pemphigus Vulgaris Market, by Distribution Channel
    - Hospital Pharmacies
    - Retail Pharmacies
    - Others
  - South Africa
    - South Africa Pemphigus Vulgaris Market, by Therapy Type
      - Anti-CD20 monoclonal antibodies (rituximab)
      - Systemic corticosteroids
      - Conventional steroid-sparing immunosuppressants
      - Intravenous immunoglobulin (IVIG) - adjunct
      - Topical therapies
    - South Africa Pemphigus Vulgaris Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Saudi Arabia
    - Saudi Arabia Pemphigus Vulgaris Market, by Therapy Type
      - Anti-CD20 monoclonal antibodies (rituximab)
      - Systemic corticosteroids
      - Conventional steroid-sparing immunosuppressants
      - Intravenous immunoglobulin (IVIG) - adjunct
      - Topical therapies
    - Saudi Arabia Pemphigus Vulgaris Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - UAE
    - UAE Pemphigus Vulgaris Market, by Therapy Type
      - Anti-CD20 monoclonal antibodies (rituximab)
      - Systemic corticosteroids
      - Conventional steroid-sparing immunosuppressants
      - Intravenous immunoglobulin (IVIG) - adjunct
      - Topical therapies
    - UAE Pemphigus Vulgaris Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Kuwait
    - Kuwait Pemphigus Vulgaris Market, by Therapy Type
      - Anti-CD20 monoclonal antibodies (rituximab)
      - Systemic corticosteroids
      - Conventional steroid-sparing immunosuppressants
      - Intravenous immunoglobulin (IVIG) - adjunct
      - Topical therapies
    - Kuwait Pemphigus Vulgaris Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments